Skip to main content

Table 1 Baseline demographic and clinical characteristics of the study cohort

From: Neurological, functional, and quality of life outcomes following combined mesenchymal stem cell and Schwann cell therapy in spinal cord injury: a 9-year experience

Characteristic

Total (n = 106)

Cervical (n = 32)

Thoracolumbar (n = 74)

Subacute (n = 29)

Chronic (n = 77)

Age years– mean (SD)

31.5 (10.0)

31.8 (11.9)

31.4 (9.2)

32.0 (9.8)

31.4 (10.2)

Sex– no. (%)

Male

89 (84.0%)

26 (24.5%)

63 (59.4%)

24 (22.6%)

65 (61.3%)

Female

17 (16.0%)

6 (5.7%)

11 (10.4%)

5 (4.7%)

12 (11.3%)

Level of injury– no. (%)

Cervical

32 (30.2%)

-

-

6 (5.7%)

26 (24.5%)

Thoracolumbar

74 (69.8%)

-

-

23 (21.7%)

51 (48.1%)

Duration of injury

23.9 (32.1)

33.0 (50.2)

20.0 (19.0)

3.9 (1.7)

31.4 (34.8)

Chronicity– no. (%)

Subacute (< 6 months)

29 (27.4%)

6 (5.7%)

23 (21.7%)

-

-

Chronic (> 6 months)

77 (72.6%)

26 (24.5%)

51 (48.1%)

-

-

Cause of injury– no. (%)

Road traffic accident

77 (72.6%)

22 (20.8%)

55 (51.9%)

25 (23.6%)

52 (49.1%)

Fall

21 (19.8%)

6 (5.7%)

15 (14.2%)

1 (0.9%)

20 (18.9%)

Other traumatic

5 (4.7%)

3 (2.8%)

2 (1.9%)

3 (2.8%)

2 (1.9%)

Non-traumatic

3 (2.8%)

1 (0.9%)

2 (1.9%)

0 (0.0%)

3 (2.8%)

  1. SD: standard deviation; no.: number